CovalX Revenue
Biotechnology Research • 
Mühlebachstrasse 14, Zurich, Switzerland • 11-20 Employees
CovalX revenue & valuation
| Annual revenue | $48,100,000 |
| Revenue per employee | $2,668,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $153,700,000 |
| Total funding | No funding |
Key Contacts at CovalX
Ryan Wenzel
Director Of North American Operations
Alexis Nazabal
Ceo
Company overview
| Headquarters | Mühlebachstrasse 14, Zurich, 8008, CH |
| Phone number | +41445853964 |
| Website | |
| NAICS | 541714 |
| SIC | 382 |
| Keywords | Enzymes, Biotherapeutics, Antibody Characterization, High Mass Protein, Protein Complex, Protein:Protein Interactions - Ppi, Therapeutic Aggregates Or Aggregation, Large Molecules, Monoclonal Antibody, Amino Acids, Epitope Mapping, Hdx-Ms, De Novo Sequencing, Disulfide Mapping, Epitope Mapping Services, Ich-Q6B Analysis, Intact Maldi-Ms, Pmf Analysis, Ptm Analysis, Spr Analysis, Xl-Ms, Conformational Analysis By Hdx-Ms, Mab Characterization |
| Founded | 2005 |
| Employees | 11-20 |
| Socials |
CovalX Email Formats
CovalX uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@covalx.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@covalx.com | 66.7% |
{first name}.{last name} | john.doe@covalx.com | 33.3% |
About CovalX
CovalX has been established as the leader in characterizing protein interactions by mass spectrometry. Providing Innovative Technologies and Exclusive Services, CovalX has been doing business with world-renowned Universities, therapeutic companies, and most major pharmaceutical companies worldwide for many years. CovalX AG developed a unique protocol for measuring intact protein complexes using MALDI mass spectrometry. CovalX both sells the tools and/or services for High-Mass MALDI protein-protein interaction analysis. The main applications involve: • Epitope mapping (both conformational or linear) • Characterizing aggregates from biotherapeutic drugs • Analyzing antibody-antigen interactions • rapid characterization of any protein complexes (stoichiometry, inhibition, etc) CovalX also has flexibility and provides services for characterizing any large macro molecules such as PEGylated proteins or polymers. CovalX has recently restructured by moving some of its hardware support facilities and US sales and marketing into the US and establishing an official subsidiary in the Boston area.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
CovalX has 13 employees across 5 departments.
Departments
Number of employees
Funding Data
CovalX has never raised funding before.
CovalX Tech Stack
Discover the technologies and tools that power CovalX's digital infrastructure, from frameworks to analytics platforms.
Performance
Security
Form builders
Cookie compliance
Analytics
JavaScript libraries
CDN
JavaScript libraries
Analytics
Miscellaneous
Programming languages
Spain
United Kingdom
Germany
Netherlands
Canada
Frequently asked questions
4.8
40,000 users
